MOTS-c

What it is?

MOTS-c is a mitochondrially derived peptide studied for its role in metabolic regulation and cellular resilience. It is commonly positioned within longevity and performance frameworks where metabolic flexibility, insulin sensitivity, and mitochondrial adaptation are primary endpoints.

Dripfy Advantage

• AMPK pathway activation: Engages signalling associated with AMPK, supporting metabolic flexibility and energy-sensing regulation.
• Glucose utilisation dynamics: Positioned to enhance glucose uptake and utilisation markers, supporting improved metabolic efficiency.
• Insulin sensitivity support: Associated with improved insulin signalling and sensitivity indices in structured metabolic protocols.
• Mitochondrial biogenesis signalling: Supports pathways linked to mitochondrial biogenesis, contributing to cellular energy capacity and resilience.
• Exercise-adaptation alignment: Frequently positioned for protocols tracking endurance, recovery readiness, and performance adaptation endpoints.

Clinical Applications & Therapeutic Potential

• Metabolic health optimisation: Potential support for improved insulin sensitivity markers and glycaemic control endpoints.
• Endurance and performance outcomes: Potential improvements in endurance-related endpoints via enhanced cellular energy and metabolic flexibility.
• Longevity via metabolic efficiency: Positioned for anti-ageing frameworks through optimisation of mitochondrial and metabolic pathways.
• Body composition endpoints: Potential support for favourable fat-to-lean ratio markers and improved composition control in structured programs.

Composition & Formulation

• Peptide Content: 10 mg MOTS-c
• Vehicle: Proprietary pH-balanced buffer solution
• Delivery System: Pre-filled, multi-dose, closed-system pen
• Total Volume: 3 mL
• Purity: ≥99% by HPLC/MS